The molecular arms race between African trypanosomes and humans

Nature Reviews Microbiology

Volumn 12, Issue 8, 2014, Pages 575-584

  Pays, Etienne ^a   Vanhollebeke, Benoit ^a   Uzureau, Pierrick ^a   Lecordier, Laurence ^a   Pérez Morga, David ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALS; APOLIPOPROTEINS; BIOLOGICAL EVOLUTION; DISEASE RESISTANCE; HUMANS; LIPOPROTEINS, HDL; TRYPANOSOMA BRUCEI GAMBIENSE; TRYPANOSOMA BRUCEI RHODESIENSE; TRYPANOSOMIASIS, AFRICAN;

EID: 84904511741     PISSN: 17401526     EISSN: 17401534     Source Type: Journal    
DOI: 10.1038/nrmicro3298     Document Type: Review

References (91)

1. Simarro, P. P., Diarra, A., Ruiz Postigo, J. A., Franco, J. R. & Jannin, J. G. The human African trypanosomiasis control and surveillance programme of the World Health Organization 2000-2009: the way forward. PLoS Negl. Trop. Dis. 5, e1007 (2011).
2. MacGregor, P., Szöor, B., Savill, N. J. & Matthews, K. R. Trypanosomal immune evasion, chronicity and transmission: an elegant balancing act. Nature Rev. Microbiol. 10, 431-438 (2012).
3. Simarro, P. P. et al. The Atlas of human African trypanosomiasis: a contribution to global mapping of neglected tropical diseases. Int. J. Health Geogr. 9, 57 (2010).
4. Hajduk, S. L. et al. Lysis of Trypanosoma brucei by a toxic subspecies of human high density lipoprotein. J. Biol. Chem. 264, 5210-5217 (1989).
5. Raper, J., Fung, R., Ghiso, J., Nussenzweig, V. & Tomlinson, S. Characterization of a novel trypanosome lytic factor from human serum. Infect. Immun. 67, 1910-1916 (1999).
6. Pays, E. et al. The trypanolytic factor of human serum. Nature Rev. Microbiol. 4, 477-486 (2006).
7. Drain, J., Bishop, J. R. & Hajduk, S. L. Haptoglobin-related protein mediates trypanosome lytic factor binding to trypanosomes. J. Biol. Chem. 276, 30254-30260 (2001).
8. Vanhollebeke, B. et al. Distinct roles of haptoglobin-related protein and apolipoprotein L-I in trypanolysis by human serum. Proc. Natl Acad. Sci. USA 104, 4118-4123 (2007).
9. Molina-Portela, M. P., Samanovic, M. & Raper, J. Distinct roles of apolipoprotein components within the trypanosome lytic factor complex revealed in a novel transgenic mouse model. J. Exp. Med. 205, 1721-1728 (2008).
10. Mikkelsen, T. S. et al. Initial sequence of the chimpanzee genome and comparison with the human genome. Nature 437, 69-87 (2005).
11. Maeda, N. Nucleotide sequence of the haptoglobin and haptoglobin-related gene pair. The haptoglobin-related gene contains a retrovirus-like element. J. Biol. Chem. 260, 6698-6709 (1985).
12. Widener, J., Nielsen, M. J., Shiflett, A., Moestrup, S. K. & Hajduk, S. Haemoglobin is a co-factor of human trypanosome lytic factor. PLoS Pathog. 3, 1250-1261 (2007).
13. Vanhollebeke, B. et al. A haptoglobin-haemoglobin receptor conveys innate immunity to Trypanosoma brucei in humans. Science 320, 677-681 (2008).
14. Vanhollebeke, B. & Pays, E. The trypanolytic factor of human serum: many ways to enter the parasite, a single way to kill. Mol. Microbiol. 76, 806-814 (2010).
15. Smith, A. B., Esko, J. D. & Hajduk, S. L. Killing of trypanosomes by the human haptoglobin-related protein. Science 268, 284-286 (1995).
16. Harrington, J. M., Howell, S. & Hajduk, S. L. Membrane permeabilization by trypanosome lytic factor, a cytolytic human high density lipoprotein. J. Biol. Chem. 284, 13505-13512 (2009).
17. Harrington, J. M. et al. The plasma membrane of bloodstream-form African trypanosomes confers susceptibility and specificity to killing by hydrophobic peptides. J. Biol. Chem. 285, 28659-28666 (2010).
18. Molina-Portela Mdel, P., Raper, J. & Tomlinson, S. An investigation into the mechanism of trypanosome lysis by human factors. Mol. Biochem. Parasitol. 110, 273-282 (2000).
19. Vanhollebeke, B. et al. Human Trypanosoma evansi infection linked to a lack of apolipoprotein L-I. New Engl. J. Med. 355, 2752-2756 (2006).
20. Hatada, S. et al. No trypanosome lytic activity in the sera of mice producing human haptoglobin-related protein. Mol. Biochem. Parasitol. 119, 291-294 (2002).
21. Bullard, W. et al. Haptoglobin-hemoglobin receptor independent killing of African trypanosomes by human serum and trypanosome lytic factors. Virulence 3, 72-76 (2012).
22. Raper, J., Nussenzweig, V. & Tomlinson, S. Lack of correlation between haptoglobin concentration and trypanolytic activity of normal human serum. Mol. Biochem. Parasitol. 76, 337-338 (1996).
23. Binder, C. J. Naturally occurring IgM antibodies to oxidation-specific epitopes. Adv. Exp. Med. Biol. 750, 2-13 (2012).
24. Gerencer, M., Barrett, P. N., Kistner, O., Mitterer, A. & Dorner, F. Natural IgM antibodies in baby rabbit serum bind high-mannose glycans on HIV type 1 glycoprotein 120/160 and activate classic complement pathway. AIDS Res. Hum. Retroviruses. 14, 599-605 (1998).
25. Müller, N., Mansfield, J. M. & Seebeck, T. Trypanosome variant surface glycoproteins are recognized by self-reactive antibodies in uninfected hosts. Infect. Immun. 64, 4593-4597 (1996).
26. 2+ is essential cofactor of trypanocidal activity of normal human serum. Nature 282, 613-615 (1979).
27. Vanhamme, L. et al. Apolipoprotein L-I is the trypanosome lytic factor of human serum. Nature 422, 83-87 (2003).
28. Duchateau, P. N. et al. Apolipoprotein L, a new human high density lipoprotein apolipoprotein expressed by the pancreas. Identification, cloning, characterization, and plasma distribution of apolipoprotein L. J. Biol. Chem. 272, 25576-25582 (1997).
29. Page, N. M., Butlin, D. J., Lomthaisong, K. & Lowry, P. J. The human apolipoprotein L gene cluster: identification, classification, and sites of distribution. Genomics 74, 71-78 (2001).
30. Vanhollebeke, B. & Pays, E. The function of apolipoproteins L. Cell. Mol. Life Sci. 63, 1937-1944 (2006).
31. Pérez-Morga, D. et al. Apolipoprotein L-I promotes trypanosome lysis by forming pores in lysosomal membranes. Science 309, 469-472 (2005).
32. Oli, M. W., Cotlin, L. F., Shiflett, A. M. & Hajduk, S. L. Serum resistance-associated protein blocks lysosomal targeting of trypanosome lytic factor in Trypanosoma brucei. Eukaryot. Cell 5, 132-139 (2006).
33. Stephens, N. A. & Hajduk, S. L. Endosomal localization of the serum resistance-associated protein in African trypanosomes confers human infectivity. Eukaryot. Cell 10, 1023-1033 (2011).
34. Uzureau, P. et al. Mechanism of Trypanosoma gambiense resistance to human serum. Nature 501, 430-434 (2013).
35. Molina-Portela Mdel, P., Lugli, E. B., Recio-Pinto, E. & Raper, J. Trypanosome lytic factor, a subclass of high-density lipoprotein, forms cation-selective pores in membranes. Mol. Biochem. Parasitol. 144, 218-226 (2005).
36. Lecordier, L. et al. C-terminal mutants of apolipoprotein L-I efficiently kill both Trypanosoma brucei brucei and Trypanosoma brucei rhodesiense. PLoS Pathog. 5, e1000685 (2009).
37. Roy, A., Kucukural, A. & Zhang, Y. I-TASSER: a unified platform for automated protein structure and function prediction. Nature Protoc. 5, 725-738 (2010).
38. Vanhollebeke, B., Lecordier, L., Perez-Morga, D., Amiguet-Vercher, A. & Pays, E. Human serum lyses Trypanosoma brucei by triggering uncontrolled swelling of the parasite lysosome. J. Eukaryot. Microbiol. 54, 448-451 (2007).
39. Shiflett, A. M. et al. African trypanosomes: intracellular trafficking of host defense molecules. J. Eukaryot. Microbiol. 54, 18-21 (2007).
40. Boya, P. & Kroemer, G. Lysosomal membrane permeabilization in cell death. Oncogene 27, 6434-6451 (2008).
41. Muranjan, M., Nussenzweig, V. & Tomlinson, S. Characterization of the human serum trypanosome toxin, haptoglobin-related protein. J. Biol. Chem. 273, 3884-3887 (1998).
42. Raper, J., Nussenzweig, V. & Tomlinson, S. The main lytic factor of Trypanosoma brucei brucei in normal human serum is not high density lipoprotein. J. Exp. Med. 183, 1023-1029 (1996).
43. Smith, A. B. & Hajduk, S. L. Identification of haptoglobin as a natural inhibitor of trypanocidal activity in human serum. Proc. Natl Acad. Sci. USA 92, 10262-10266 (1995).
44. Rougemont, A. et al. Hypohaptoglobinaemia as an epidemiological and clinical indicator for malaria. Results of studies in a hyperendemic region in West Africa. Lancet 2, 709-712 (1988).
45. Alsford, S., Currier, R. B., Guerra-Assunçao, J. A., Clark, T. G. & Horn, D. Cathepsin-L can resist lysis by human serum in Trypanosoma brucei brucei. PLoS Pathog. 10, e1004130 (2014).
46. Cascales, E. et al. Colicin biology. Microbiol. Mol. Biol. Rev. 71, 158-229 (2007).
47. Gibson, W. Resolution of the species problem in African trypanosomes. Int. J. Parasitol. 37, 829-838 (2007).
48. Xong, H. V. et al. A VSG expression site-associated gene confers resistance to human serum in Trypanosoma rhodesiense. Cell 95, 839-846 (1998).
49. Campillo, N. & Carrington, M. The origin of the serum resistance associated (SRA) gene and a model of the structure of the SRA polypeptide from Trypanosoma brucei rhodesiense. Mol. Biochem. Parasitol. 127, 79-84 (2003).
50. Vanhamme, L. et al. The Trypanosoma brucei reference strain TREU927/4 contains T. brucei rhodesiense-specific SRA sequences, but displays a distinct phenotype of relative resistance to human serum. Mol. Biochem. Parasitol. 135, 39-47 (2004).
51. Wang, J., Böhme, U. & Cross, G. A. Structural features affecting variant surface glycoprotein expression in Trypanosoma brucei. Mol. Biochem. Parasitol. 128, 135-145 (2003).
52. Berberof, M., Pérez-Morga, D. & Pays, E. A receptor-like flagellar pocket glycoprotein specific to Trypanosoma brucei gambiense. Mol. Biochem. Parasitol. 113, 127-138 (2001).
53. Felu, C., Pasture, J., Pays, E. & Pérez-Morga, D. Diagnosis potential of a conserved genomic rearrangement in the Trypanosoma brucei gambiense-specific TGSGP locus. Am. J. Trop. Med. Hyg. 76, 922-929 (2007).
54. Radwanska, M. et al. Novel primer sequences for a polymerase chain reaction-based detection of Trypanosoma brucei gambiense. Am. J. Trop. Med. Hyg. 67, 289-295 (2002).
55. Gibson, W., Nemetschke, L. & Ndung'u, J. Conserved sequence of the TgsGP gene in Group 1 Trypanosoma brucei gambiense. Infect. Genet. Evol. 10, 453-458 (2010).
56. Radwanska, M. et al. The serum resistance-associated gene as a diagnostic tool for the detection of Trypanosoma brucei rhodesiense. Am. J. Trop. Med. Hyg. 67, 684-690 (2002).
57. Capewell, P. et al. The TgsGP gene is essential for resistance to human serum in Trypanosoma brucei gambiense. PLoS Pathog. 9, e1003686 (2013).
58. Kieft, R. et al. Mechanism of Trypanosoma brucei gambiense (group 1) resistance to human trypanosome lytic factor. Proc. Natl Acad. Sci. USA 107, 16137-16141 (2010).
59. Symula, R. E. et al. Trypanosoma brucei gambiense group 1 is distinguished by a unique amino acid substitution in the HpHb receptor implicated in human serum resistance. PLoS Negl. Trop. Dis. 6, e1728 (2012).
60. Higgins, M. K. et al. Structure of the trypanosome haptoglobin- haemoglobin receptor and implications for nutrient uptake and innate immunity. Proc. Natl Acad. Sci. USA 110, 1905-1910 (2013).
61. Dejesus, E., Kieft, R., Albright, B., Stephens, N. A. & Hajduk, S. L. A single amino acid substitution in the group 1 Trypanosoma brucei gambiense haptoglobin- haemoglobin receptor abolishes TLF-1 binding. PLoS Pathog. e1003317 (2013).
62. Piel, F. B. et al. Global distribution of the sickle cell gene and geographical confirmation of the malaria hypothesis. Nature Commun. 1, 104 (2010).
63. Cyrklaff, M. et al. Hemoglobins S and C interfere with actin remodeling in Plasmodium falciparum-infected erythrocytes. Science 334, 1283-1286 (2011).
64. Salmon, D. et al. Characterization of the ligand-binding site of the transferrin receptor in Trypanosoma brucei demonstrates a structural relationship with the N-terminal domain of the variant surface glycoprotein. EMBO J. 16, 7272-7278 (1997).
65. Pays, E., Lips, S., Nolan, D. P., Vanhamme, L. & Pérez-Morga, D. The VSG expression sites of Trypanosoma brucei: multipurpose tools for the adaptation of the parasite to mammalian hosts. Mol. Biochem. Parasitol. 114, 1-16 (2001).
66. Thomson, R., Molina-Portela, P., Mott, H., Carrington, M. & Raper, J. Hydrodynamic gene delivery of baboon trypanosome lytic factor eliminates both animal and human-infective African trypanosomes. Proc. Natl Acad. Sci. USA 106, 19509-19514 (2009).
67. Genovese, G. et al. Association of trypanolytic apoL1 variants with kidney disease in African-Americans. Science 329, 841-845 (2010).
68. Thomson, R. et al. Evolution of the primate trypanolytic factor APOL1. Proc. Natl Acad. Sci. USA 111, E2130-E2139 (2014).
69. Kopp, J. B. et al. APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy. J. Am. Soc. Nephrol. 22, 2129-2137 (2011).
70. Foster, M. C. et al. APOL1 variants associate with increased risk of CKD among African Americans. J. Am. Soc. Nephrol. 24, 1484-1491 (2013).
71. Genovese, G., Friedman, D. J. & Pollak, M. R. APOL1 variants and kidney disease in people of recent African ancestry. Nature Rev. Nephrol. 9, 240-244 (2013).
72. Johnstone, D. B. et al. APOL1 null alleles from a rural village in India do not correlate with glomerulosclerosis. PLoS ONE 7, e51546 (2012).
73. Freedman, B. I. et al. Apolipoprotein L1 nephropathy risk variants associate with HDL subfraction concentration in African Americans. Nephrol. Dial. Transplant. 26, 3805-3810 (2011).
74. Wan, G. et al. Apolipoprotein L1, a novel Bcl-2 homology domain 3-only lipid-binding protein, induces autophagic cell death. J. Biol. Chem. 283, 21540-21549 (2008).
75. Zhaorigetu, S., Yang, Z., Toma, I., McCaffrey, T. A. & Hu, C. A. Apolipoprotein L6, induced in atherosclerotic lesions, promotes apoptosis and blocks Beclin1-dependent autophagy in atherosclerotic cells. J. Biol. Chem. 286, 27389-27398 (2011).
76. Liao, W. et al. A novel anti-apoptotic role for apolipoprotein L2 in IFN-γ-induced cytotoxicity in human bronchial epithelial cells. J. Cell. Physiol. 226, 397-406 (2011).
77. Smith, E. E. & Malik, H. S. The apolipoprotein L family of programmed cell death and immunity genes rapidly evolved in primates at discrete sites of host- pathogen interactions. Genome Res. 19, 850-858 (2009).
78. Taylor, H. E., Khatua, A. K. & Popik, W. The innate immune factor apolipoprotein L1 (APOL1) restricts HIV-1 infection. J. Virol. 88, 592-603 (2014).
79. Hartleben, B. et al. Autophagy influences glomerular disease susceptibility and maintains podocyte homeostasis in aging mice. J. Clin. Invest. 120, 1084-1096 (2010).
80. Ko, W. Y. et al. Identifying Darwinian selection acting on different human APOL1 variants among diverse African populations. Am. J. Hum. Genet. 93, 54-66 (2013).
81. Kageruka, P. et al. Infectivity of Trypanosoma (Trypanozoon) brucei gambiense for baboons (Papio hamadryas, Papio papio). Ann. Soc. Belg. Med. Trop.71, 39-46 (1991).
82. Willyard, C. Putting sleeping sickness to bed. Nature Med. 17, 14-17 (2011).
83. Salmon, D. et al. Adenylate cyclases of Trypanosoma brucei inhibit the innate immune response of the host. Science 337, 463-466 (2012).
84. Bosschaerts, T., Guilliams, M., Stijlemans, B., De Baetselier, P. & Beschin, A. Understanding the role of monocytic cells in liver inflammation using parasite infection as a model. Immunobiology 214, 737-747 (2009).
85. Paulnock, D. M., Freeman, B. E. & Mansfield, J. M. Modulation of innate immunity by African trypanosomes. Parasitology 137, 2051-2063 (2010).
86. Morrison, L. J. Parasite-driven pathogenesis in Trypanosoma brucei infections. Parasite Immunol. 33, 448-455 (2011).
87. Tabel, H., Wei, G. & Bull, H. J. Immunosuppression: cause for failures of vaccines against African Trypanosomiases. PLoS Negl. Trop. Dis. 7, e2090 (2013).
88. Hall, J. P., Wang, H. & Barry, J. D. Mosaic VSGs and the scale of Trypanosoma brucei antigenic variation. PLoS Pathog. 9, e1003502 (2013).
89. Blum, M. L. et al. A structural motif in the variant surface glycoproteins of Trypanosoma brucei. Nature 362, 603-609 (1993).
90. Chattopadhyay, A. et al. Structure of the C-terminal domain from Trypanosoma brucei variant surface glycoprotein MITat1.2. J. Biol. Chem. 280, 7228-7235 (2005).
91. Morrison, L. J., Marcello, L. & McCulloch, R. Antigenic variation in the African trypanosome: molecular mechanisms and phenotypic complexity. Cell. Microbiol. 11, 1724-1734 (2009).